Hum Vaccin Immunother

• 

  Publication Venue For

  • Emerging immunotherapies for autoimmune kidney disease..  15:876-890. 2019
  • Evaluation of two frailty indices, with practical application in a vaccine clinical trial..  15:2960-2968. 2019
  • Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines..  13:2996-3009. 2017
  • Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV..  13:2726-2737. 2017
  • Effect of antipyretic analgesics on immune responses to vaccination..  12:2391-2402. 2016
  • Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus..  11:504-515. 2015
  • Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques..  9:2081-2094. 2013
  • Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia..  9:2069-2080. 2013
  • High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088)..  9:957-968. 2013
  • Vaccination against herpes zoster in developed countries: state of the evidence..  9:1177-1184. 2013
  • IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques..  8:1620-1629. 2012
  • Future therapies for food allergy..  8:1479-1484. 2012
  • Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy..  10. 2014
  • Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy..  10:2507-2511. 2014
  • Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity. 2020